Literature DB >> 34894974

Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion.

Susanna B Park1, Stefano Tamburin2, Angelo Schenone3,4, Ian R Kleckner5, Roser Velasco6,7, Paola Alberti8, Grace Kanzawa-Lee9, Maryam Lustberg10, Susan G Dorsey11, Elisa Mantovani2, Mehrnaz Hamedani3, Andreas A Argyriou12, Guido Cavaletti8, Ahmet Hoke13.   

Abstract

INTRODUCTION: Chemotherapy-induced peripheral neurotoxicity (CIPN) remains a significant toxicity in cancer survivors without preventative strategies or rehabilitation. Exercise and physical activity-based interventions have demonstrated promise in reducing existing CIPN symptoms and potentially preventing toxicity, however there is a significant gap in evidence due to the lack of quality clinical trials and appropriate outcome measures. AREAS COVERED: We systematically reviewed outcome measures in CIPN exercise and physical rehabilitation studies with expert panel consensus via the Peripheral Nerve Society Toxic Neuropathy Consortium to provide recommendations for future trials. Across 26 studies, 75 outcome measures were identified and grouped into 16 domains within three core areas - measures of manifestations of CIPN (e.g. symptoms/signs), measures of the impact of CIPN and other outcome measures. EXPERT OPINION: This article provides a conceptual framework for CIPN outcome measures and highlights the need for definition of a core outcome measures set. The authors provide recommendations for CIPN exercise and physical rehabilitation trial design and outcome measure selection. The development of a core outcome measure set will be critical in the search for neuroprotective and treatment approaches to support cancer survivors and to address the gap in the identification of effective rehabilitation and treatment options for CIPN.

Entities:  

Keywords:  Chemotherapy induced peripheral neurotoxicity; cancer survivorship; exercise; neurotoxicity; outcome measures; peripheral neuropathy; rehabilitation; treatment

Mesh:

Substances:

Year:  2022        PMID: 34894974      PMCID: PMC8963967          DOI: 10.1080/14737175.2022.2018300

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.287


  51 in total

Review 1.  Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings.

Authors:  Andreas A Argyriou; Susanna B Park; Badrul Islam; Stefano Tamburin; Roser Velasco; Paola Alberti; Jordi Bruna; Dimitri Psimaras; Guido Cavaletti; David R Cornblath
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-06-29       Impact factor: 10.154

Review 2.  A systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms.

Authors:  Mary Anne Lagmay Tanay; Jo Armes; Rona Moss-Morris; Anne Marie Rafferty; Glenn Robert
Journal:  J Cancer Surviv       Date:  2021-03-12       Impact factor: 4.442

3.  Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up.

Authors:  B Jordan; A Margulies; F Cardoso; G Cavaletti; H S Haugnes; P Jahn; E Le Rhun; M Preusser; F Scotté; M J B Taphoorn; K Jordan
Journal:  Ann Oncol       Date:  2020-07-30       Impact factor: 32.976

4.  Effect of Exercise on Taxane Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial.

Authors:  Kelcey A Bland; Amy A Kirkham; Joshua Bovard; Tamara Shenkier; David Zucker; Donald C McKenzie; Margot K Davis; Karen A Gelmon; Kristin L Campbell
Journal:  Clin Breast Cancer       Date:  2019-06-27       Impact factor: 3.225

5.  The Effect of Therapeutic Exercises on Balance, Quality of Life, and Pain in Patients Who Were Receiving Neurotoxic Chemotherapy.

Authors:  Yeliz Bahar-Ozdemir; Gulseren Akyuz; Melihat Kalkandelen; Perran Fulden Yumuk
Journal:  Am J Phys Med Rehabil       Date:  2020-04       Impact factor: 2.159

6.  Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.

Authors:  Kathleen A Griffith; Susan G Dorsey; Cynthia L Renn; Shijun Zhu; Mary E Johantgen; David R Cornblath; Andreas A Argyriou; Guido Cavaletti; Ingemar S J Merkies; Paola Alberti; Tjeerd J Postma; Emanuela Rossi; Barbara Frigeni; Jordi Bruna; Roser Velasco; Haralabos P Kalofonos; Dimitri Psimaras; Damien Ricard; Andrea Pace; Edvina Galie; Chiara Briani; Chiara Dalla Torre; Catharina G Faber; Roy I Lalisang; Willem Boogerd; Dieta Brandsma; Susanne Koeppen; Joerg Hense; Dawn J Storey; Simon Kerrigan; Angelo Schenone; Sabrina Fabbri; Maria Grazia Valsecchi
Journal:  J Peripher Nerv Syst       Date:  2014-06       Impact factor: 3.494

7.  Exercise improves functional capacity and lean body mass in patients with gastrointestinal cancer during chemotherapy: a single-blind RCT.

Authors:  Katrin Stuecher; Claus Bolling; Lutz Vogt; Daniel Niederer; Katharina Schmidt; Axel Dignaß; Winfried Banzer
Journal:  Support Care Cancer       Date:  2018-10-04       Impact factor: 3.603

8.  The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale.

Authors:  Guido Cavaletti; Barbara Frigeni; Francesca Lanzani; Marialuisa Piatti; Stefania Rota; Chiara Briani; Gabriella Zara; Rosaria Plasmati; Francesca Pastorelli; Augusto Caraceni; Andrea Pace; Mariagrazia Manicone; Andrea Lissoni; Nicoletta Colombo; Giulia Bianchi; Claudio Zanna
Journal:  J Peripher Nerv Syst       Date:  2007-09       Impact factor: 3.494

Review 9.  Cancer-induced muscle wasting: latest findings in prevention and treatment.

Authors:  Zaira Aversa; Paola Costelli; Maurizio Muscaritoli
Journal:  Ther Adv Med Oncol       Date:  2017-03-08       Impact factor: 8.168

Review 10.  Chemotherapy-induced peripheral neurotoxicity: a critical analysis.

Authors:  Susanna B Park; David Goldstein; Arun V Krishnan; Cindy S-Y Lin; Michael L Friedlander; James Cassidy; Martin Koltzenburg; Matthew C Kiernan
Journal:  CA Cancer J Clin       Date:  2013 Nov-Dec       Impact factor: 508.702

View more
  1 in total

Review 1.  Axillary Web Syndrome in Breast Cancer Women: What Is the Optimal Rehabilitation Strategy after Surgery? A Systematic Review.

Authors:  Lorenzo Lippi; Alessandro de Sire; Luigi Losco; Kamal Mezian; Arianna Folli; Mariia Ivanova; Lorenzo Zattoni; Stefano Moalli; Antonio Ammendolia; Carmine Alfano; Nicola Fusco; Marco Invernizzi
Journal:  J Clin Med       Date:  2022-07-01       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.